Roles of E2F1 in mesangial cell proliferation in vitro

Kidney International

Volumn 56, Issue 6, 1999, Pages 2085-2095

  Inoshita, Seiji ^a   Terada, Yoshio ^a   Nakashima, Osamu ^a   Kuwahara, Michio ^a   Sasaki, Sei ^a   Marumo, Fumiaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cell cycle; G1 S cell phase; Glomerulonephritis; Transcription factor

Indexed keywords

CASPASE 3; CYCLIN A; CYCLIN D1; CYCLIN E; CYCLINE; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; ARTICLE; CELL COUNT; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; DNA SYNTHESIS; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE TRANSFER; GLOMERULOPATHY; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 0033428862     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00799.x     Document Type: Article

References (56)

1. 1. Abbound HE: Growth factors in glomerulonephritis [clinical conference]. Kidney Int 43:252-267, 1993
2. 2. Floege J, Eng E, Young BA, Johnson RJ: Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int 39(Suppl):S47-S54, 1993
3. 3. Clarkson AR, Woodroffe AJ, Bannister KM, Odum J, Thomas A: Therapy in IgA nephropathy. Contrib Nephrol 104:189-197, 1993
4. 4. Glassock RJ: Treatment of immunologically mediated glomerular disease. Kidney Int 38(Suppl):S121-S126, 1992
5. 5. Shankland SJ, Hamel P, Scholey JW: Cyclin and cyclin-dependent kinase expression in the remnant glomerulus. J Am Soc Nephrol 8:368-375, 1997
6. 6. Terada Y, Yamada T, Nakashima O, Tamamori M, Ito H, Sasaki S, Marumo F: Overexpression of cell cycle inhibitors (p161NK4 and p21Cip1) and cyclin D1 using adenovirus vectors regulates proliferation of rat mesangial cells. J Am Soc Nephrol 8:51-60, 1997
7. 7. Schoecklmann HO, Rupprecht HD, Zauner I, Sterzel RB: TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation. Kidney Int 51:1228-1236, 1997
8. Kipt. Kidney Int 51:1088-1099, 1997
9. 9. Terada Y, Inoshita S, Nakashima O, Yamada T, Tamamori M, Ito H, Sasaki S, Marumo F: Cyclin D1, p16, and retinoblastoma gene regulate mitogenic signaling of endothelin in rat mesangial cells. Kidney Int 53:76-83, 1998
10. 10. Shankland SJ, Floege J, Thomas SE, Nangaku M, Hugo C, Pippin J, Henne K, Hockenberry DM, Johnson RJ, Couser WG: Cyclin kinase inhibitors arc increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int 52:404-413, 1997
11. 11. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livingston DM: Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497, 1993
12. 12. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ: Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the eyclin d-dependent kinase CDK4. Genes Dev 7:331-342, 1993
13. 13. Ivey-Hoyle M, Conroy R, Huber HE, Goodhart PJ, Oliff A, Heimbrook DC: Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol Cell Biol 13:7802-7812, 1993
14. 14. Lees JA, Saito M, Vidal M, Valentine M, Look T, Harlow E, Dyson N, Helin K: The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol 13:7813-7825, 1993
15. 15. Helin K, Lees JA, Vidal M, Dyson N, Harlow E, Fattaey A: A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70:337-350, 1992
16. 16. Sardet C, Vidal M, Cobrinik D, Geng Y, Onufryk C, Chen A, Weinberg RA: E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci USA 92:2403-2407, 1995
17. 17. Weinberg RA: E2F and cell proliferation: A world turned upside down. Cell 85:457-459, 1996
18. 18. DeGregori J, Leone G, Ohtani K, Miron A, Nevins JR: E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev 9:2873-2887, 1995
19. 19. Johnson DG, Schwarz JK, Cress WD, Nevins JR: Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365:349-352, 1993
20. 20. Tomita N, Horiuchi M, Tomita S, Gibbons GH, Kim JYS, Baran D, Dzau VJ: An oligonucleotide decoy for transcription factor E2f inhibits mesangial cell proliferation in vitro. Am J Physiol 44:F278-F284, 1998
21. 21. Maeshima Y, Kashihara N, Yasuda T, Sugiyama H, Sekikawa T, Okamoto K, Kanao K, Watanabe Y, Kanwar YS, Makino H: Inhibition of mesangial cell proliferation by E2F decoy oligodeoxy-nucleotide in vitro and in vivo. J Clin Invest 101:2589-2597, 1998
22. 22. Muller H, Lukas J, Schneider A, Warthoe P, Bartek J, Eilers M, Strauss M: Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 91:2945-2949, 1994
23. 23. Johnson DG, Ohtani K, Nevins JR: Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev 8:1514-1525, 1994
24. 24. Ohtani K, DeGregori J, Nevins JR: Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci USA 92:12146-12150, 1995
25. 25. Motukara T, Arnold A: PRAD1/cyclin D1 proto-oncogene: Genomic organization, 5′ DNA sequence, and sequence of a tumor-specific rearrangement breakpoint. Genes Chromosom Cancer 7:89-95, 1993
26. 26. Henglein B, Chenivesse X, Wang J, Eick D, Brechot C: Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc Natl Acad Sci USA 91:5490-5494, 1994
27. 27. Pabst R, Sterzel RB: Cell renewal of glomerular cell types in normal rats: An autoradiographic analysis. Kidney Int 24:626-631, 1983
28. 28. Shankland SJ, Hugo C, Coats SR, Nangaku M, Pichler RH, Gordon KL, Pippin J, Roberts JM, Couser WG, Johnson RJ: Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int 50:1230-1239, 1996
29. 29. Schwarz JK, Bassing CH, Kovesdi I, Datto MB, Blazing M, George S, Wang XF, Nevins JR: Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression. Proc Natl Acad Sci USA 92:483-487, 1995
30. 30. Kanegae Y, Lee G, Sato Y, Tanaka M, Nakai M, Sakaki T, Sugano S, Saito I: Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res 23:3816-3821, 1995
31. 31. Owada A, Tomita K, Terada Y, Sakamoto H, Nonoguchi H, Marumo F: Endothelin (ET)-3 stimulates cyclic guanosine 3′,5′-monophosphate production via ETB receptor by producing nitric oxide in isolated rat glomerulus, and in cultured rat mesangial cells. J Clin Invest 93:556-563, 1994
32. 32. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY: d-Type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14:2066-2076, 1994
33. 33. Lindeman GJ, Gaubatz S, Livingston DM, Ginsberg D: The subcellular localization of E2F-4 is cell-cycle dependent. Proc Natl Acad Sci USA 94:5095-5100, 1997
34. 34. Verona R, Moberg K, Estes S, Starz M, Vernon JP, Lees JA: E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol Cell Biol 17:7268-7282, 1997
35. 35. Ginsberg D, Vairo G, Chittenden T, Xiao ZX, Xu G, Wydner KL, Decarpio JA, Lawrence JB, Livingston DM: E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev 8:2665-2679, 1994
36. 36. Wu X, Levine AJ: p53 and E2f-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 91:3602-3606, 1994
37. 37. Qin XQ, Livingston DM, Kaelin WG Jr, Adams PD: Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci USA 91:10918-10922, 1994
38. 38. Shan B, Lee WH: Deregulated expression of E2F-1 induces S-phase entry and leads to apoplosis. Mol Cell Biol 14:8166-8173, 1994
39. 39. Kowalik TF, DeGregori J, Schwarz JK, Nevins JR: E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J Virol 69:2491-2500, 1995
40. 40. Sherr CJ: Cancer cell cycles. Science 274:1672-1677, 1996
41. 41. Pippin JW, Qu Q, Meijer L, Shankland SJ: Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist. J Clin Invest 100:2512-2520, 1997
42. 42. Nevins JR: Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ 9:585-593, 1998
43. 43. DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR: Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA 94:7245-7250, 1997
44. 44. Nevins JR: E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429, 1992
45. 45. Shan B, Chang CY, Jones D, Lee WH: The transcription factor E2F-1 mediates the autoregulation of RB gene expression. Mol Cell Biol 14:299-309, 1994
46. 46. Thalmeier K, Synovzik H, Mertz R, Winnacker EL, Lipp M: Nuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter. Genes Dev 3:527-536, 1989
47. 47. Dalton S: Cell cycle regulation of the human cdc2 gene. EMBO J 11:1797-1804, 1992
48. 48. Yamaguchi M, Hayashi Y, Hirose F, Matsuoka S, Shiroki K, Matsukage A: Activation of the mouse proliferating cell nuclear antigen gene promoter by adenovirus type 12 E1A proteins. Jpn J Cancer Res 83:609-617, 1992
49. 49. Chittenden T, Livingston DM, Kaelin WG Jr: The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell 65:1073-1082, 1991
50. 50. Watson RJ, Dyson PJ, McMahon J: Multiple c-myb transcript cap sites are variously utilized in cells of mouse haemopoietic origin. EMBO J 6:1643-1651, 1987
51. 51. Watanabe G, Albanese C, Lee RJ, Reutens A, Vairo G, Henglein B, Pestell RG: Inhibition of cyclin D1 kinase activity is associated with E2F-mcdiated inhibition of cyclin D1 promoter activity through E2F and Spl. Mol Cell Biol 18:3212-3222, 1998
52. 52. Fan J, Bertino JR: Functional roles of E2F in cell cycle regulation. Oncogene 14:1191-1200, 1997
53. 53. Dynlacht BD, Flores O, Lees JA, Harlow E: Differential regulalion of E2F transactivation by cyclin/cdk2 complexes. Genes Dev 8:1772-1786, 1994
54. 54. Xu M, Shappard KA, Peng CY, Yee AS, Piwnica-Worms H: Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol Cell Biol 14:8420-8431, 1994
55. 55. Krek W, Xu G, Livingston DM: Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 83:1149-1158, 1995
56. 56. Morishita R, Gibbons GH, Horiuchi M, Ellison KE, Nakama M, Zhang, L, Kaneda Y, Ogihara T, Dzau VJ: A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci USA 92:5855-5859, 1995